首页> 美国卫生研究院文献>Inflammatory Bowel Diseases >A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naïve and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression
【2h】

A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naïve and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression

机译:初治和深度缓解溃疡性结肠炎患者结肠黏膜中的脂环素和内源性大麻素的定量分析及其与细胞因子基因表达的潜在关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe bioactive metabolites of omega 3 and omega 6 polyunsaturated fatty acids (ω-3 and ω-6) are known as oxylipins and endocannabinoids (eCBs). These lipid metabolites are involved in prompting and resolving the inflammatory response that leads to the onset of inflammatory bowel disease (IBD). This study aims to quantify these bioactive lipids in the colonic mucosa and to evaluate the potential link to cytokine gene expression during inflammatory events in ulcerative colitis (UC).
机译:背景ω3和ω6多不饱和脂肪酸(ω-3和ω-6)的生物活性代谢产物被称为oxylipins和内源性大麻素(eCBs)。这些脂质代谢物参与促进和解决导致炎症性肠病(IBD)发作的炎症反应。这项研究旨在量化结肠黏膜中的这些生物活性脂质,并评估溃疡性结肠炎(UC)炎症事件期间与细胞因子基因表达的潜在联系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号